MedTrace Logo

Repeated High-dose Inhaled Corticosteroids for Asthma

NCT00695604 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2018-05-08

No results posted yet for this study

Summary

The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids (ICS) vs. placebo in adults with chronic stable asthma.

Conditions

Interventions

DRUG

Placebo

Placebo via MDI.

DRUG

Fluticasone

Fluticasone MDI.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Jerry Krishnan, MD, PhD · University of Illinois at Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00695604 on ClinicalTrials.gov